In a global first, Florida Atlantic University has unveiled an unprecedented research initiative uniting advanced MRI and focused ultrasound technologies into a single, preclinical and clinical research platform that promises to accelerate the pathway from scientific discovery to patient care. This state-of-the-art initiative at the Florida Atlantic NeuroInnovate Center empowers scientists to explore the brain and body with exceptional precision, advancing the understanding of complex neurological diseases such as Alzheimer’s, Parkinson’s and more. Integrating a comprehensive “bench-to-bedside” approach, the initiative will significantly accelerate the discovery, development and delivery of new treatments, ultimately transforming patient care.

Researchers will now have access to a fully integrated system that allows them to study disease mechanisms, test treatments in real time, and apply those therapies directly to patients. It begins with the preclinical MRI, designed for research using translational models. Once a treatment shows promise, it can move seamlessly to human trials using the clinical MRI system that guides and monitors therapies in a safe, controlled setting.

Focused ultrasound uses precise acoustic energy, like sunlight through a magnifying glass, to target tissues safely. Multiple beams converge at one point, producing mechanical or thermal effects. This non-invasive, rapidly advancing therapy has growing clinical uses in a wide range of diseases including neurological disorders, cancer, cardiovascular and metabolic diseases, and pain management.